Making a toast to your health could have new meaning this holiday season. Researchers have identified a substance in red wine that may help prevent Alzheimer's disease. This ScienCentral News video explains.
New research from the Gladstone Institute of Neurological Disease details exactly how a mutant form of the protein apolipoprotein E, also known as apoE, is a causative factor for Alzheimer's disease.
In a promising step toward combating a fatal brain disease, scientists at the Buck Institute for Age Research in Novato have found that mice injected with a growth-promoting protein improved their brain function and lifespan.
The Scientist magazine announced today the winners of its annual best places to work in academia survey, naming The J. David Gladstone Institutes as one of the nation's top three academic work environments.
Injections of genetically altered cells into the brain appear to nourish ailing neurons and may slow the cognitive decline in patients with Alzheimer's disease, scientists reported yesterday in a preliminary study.
The Hereditary Disease Foundation has named Steven Finkbeiner, MD, PhD, an assistant investigator at the Gladstone Institute of Neurological Disease and assistant professor of neurology and physiology at University of California, San Francisco (UCSF), as the recipient of its highly esteemed Lieberman Award.
The J. David Gladstone Institutes, a group of UCSF-affiliated medical research institutes, is among the top 15 institutional work environments for life sciences postdoctoral fellows, according to The Scientist 's annual "Best Places to Work for Postdocs" survey, set to be published in the February 14 issue.
